Jennifer Zachary

Companies

• REGENXBIO Inc.Board member Jun 7, 2022 to now¹
• Merck & Co.General counsel Apr 17, 2018 to now²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Merck & Co. MRK45,509 shares³$6.6M at $145.87Aug 12, 2026
• RREGENXBIO Inc. RGNX31,871 shares⁴$229.9K at $7.21May 29, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Aug 12, 2026Sold 80,315 shares at $133.46 of Merck & Co.³
• Aug 12, 2026Exercised options 13,433 shares at $84.71 of Merck & Co.³
• Aug 12, 2026Exercised options 41,494 shares at $117.89 of Merck & Co.³
• May 29, 2026Granted 9,807 shares of REGENXBIO Inc.⁴
• Apr 29, 2026Shares withheld for tax 1,454 shares at $110.03 of Merck & Co.⁵
• Apr 29, 2026Exercised options 2,951 shares at $110.03 of Merck & Co.⁵
• Feb 9, 2026Sold 38,835 shares at $119.15 of Merck & Co.⁶
• Feb 9, 2026Exercised options 38,835 shares at $119.15 of Merck & Co.⁶
• Feb 9, 2026Sold 56,792 shares at $119.15 of Merck & Co.⁶
• Feb 9, 2026Exercised options 56,792 shares at $119.15 of Merck & Co.⁶
• Feb 9, 2026Sold 25,946 shares at $119.15 of Merck & Co.⁶
• Feb 9, 2026Exercised options 25,946 shares at $119.15 of Merck & Co.⁶
• Jan 26, 2026Granted 11,583 shares at $107.40 of Merck & Co.⁷
• May 30, 2025Granted 7,768 shares of REGENXBIO Inc.⁸
• Jan 27, 2025Granted 25,423 shares at $97.94 of Merck & Co.⁹
• May 31, 2024Granted 4,790 shares of REGENXBIO Inc.¹⁰
• Feb 2, 2024Sold 49,499 shares at $126.97 of Merck & Co.¹¹
• Feb 2, 2024Exercised options 19,417 shares at $87.10 of Merck & Co.¹¹
• Jan 22, 2024Granted 23,298 shares at $119.43 of Merck & Co.¹²
• Jun 2, 2023Granted 3,486 shares of REGENXBIO Inc.¹³
• May 4, 2023Sold 19,141 shares at $117.59 of Merck & Co.¹⁴
• Feb 3, 2023Sold 75,436 shares at $103.17 of Merck & Co.¹⁵
• Feb 3, 2023Exercised options 75,436 shares at $56.04 of Merck & Co.¹⁵
• Jan 23, 2023Granted 15,631 shares at $109.88 of Merck & Co.¹⁶
• Oct 28, 2022Sold 65,487 shares at $99.85 of Merck & Co.¹⁷